ClinicalTrials.gg
CompletedNCT03986125SASSUpdated Jul 16, 2020

Student Anxiety & Stress Study

An interventional study of Emotional Awareness & Expression Therapy and Mindfulness Meditation Training in Anxiety and Somatic Symptom Disorder, sponsored by Wayne State University. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2020-07-16.

Primary conditionMedically Unexplained SymptomsRegistry: Anxiety DisordersReclassifiedWhy we changed it
Registry
Anxiety Disorders — the first condition term the registry derived for this study.
ClinicalTrials.gg
Medically Unexplained Symptoms
Why
  1. The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it.
  2. The study's listed conditions name Medically Unexplained Symptoms.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Wayne State University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
53
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 10 studies in Medically Unexplained Symptoms with a site in United States — 4 open to participants now, 4 under way, none of them phase 3. Medically Unexplained Symptoms · United States.

Started
2019
with 1 other
No phase
9 of 10
4 open now
Registered
4th of 10
by date
Lead sponsor
2 of 10
Wayne State University

Among the 10 studies in Medically Unexplained Symptoms with a site in United States, this one is one of 2 that started in 2019, is one of 9 with no phase, and was the 4th registered.

Medically Unexplained Symptoms

71 studies on the registry are indexed under Medically Unexplained Symptoms; 22 are open to participants now.

This study's enrollment of 53 is below the median of 68 across 53 interventional studies indexed under Medically Unexplained Symptoms.

Browse Medically Unexplained Symptoms studies →

Open to participants now

4 of the 10 studies in Medically Unexplained Symptoms with a site in United States are open now, in 1 country. Each count lists the studies.

All 4 open studies →

Where they have run

Who these studies take

Of the 20 Medically Unexplained Symptoms studies recruiting now, 6 (30%) set no upper age limit and 12 (60%) stop at 75 or younger; 6 take children under 18; 9 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →
Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Medically Unexplained Symptoms with a site in United States, or all of them as a file.
02

Study summary

The present study is a randomized clinical trial of an emotional awareness and expression intervention (EAET) and a mindfulness meditation intervention (MMT) for Wayne State University students with anxiety and somatic symptoms. Each of these treatments will be compared to a wait list control condition and to one another to evaluate how well the treatments improve physical and psychological symptoms, stress, and interpersonal functioning of 120 Wayne State University students at 4-week and 8-weeks post-randomization. This research is intended to provide an evidence-based approach to working with emotions to improve both anxiety and somatic symptoms in young adults and will illuminate how EAET compares to the commonly used mindfulness training. It is hypothesized that both active interventions will be superior to no treatment, and differences between the two treatments will be explored.

Read the detailed description

Anxiety is an increasingly common condition among college students and is often accompanied by somatic symptoms. These conditions impair students' social, psychological, and academic functioning and outcomes. Although students are utilizing campus and community mental health centers at increasing rates, these resources are strained. The present study aims to test the efficacy of two brief treatment options for students.

Integrating techniques from several emotion-focused therapies, the investigators have developed and tested an intervention encouraging the awareness and expression of habitually suppressed or avoided emotions. This Emotional Awareness and Expression Therapy (EAET) has been evaluated with various patient populations including fibromyalgia, irritable bowel syndrome, chronic pelvic pain, and medically unexplained symptoms. Results of these trials suggest that the intervention is efficacious in improving physical and psychological well-being, and is equal to or superior to other psychological interventions for somatic conditions. The present study seeks to advance the EAET literature by evaluating the efficacy of the intervention for a broader population and by employing a strong and conceptually different comparison condition: mindfulness meditation training.

03

Conditions studied

  • Anxiety
  • Somatic Symptom Disorder

Browse trials for

Keywords

  • college students
  • anxiety
  • somatic symptoms
04

In context

Medically Unexplained Symptoms Reclassified

71 studies on the registry are indexed under Medically Unexplained Symptoms; 22 are open to participants now.

This study's enrollment of 53 is below the median of 68 across 53 interventional studies indexed under Medically Unexplained Symptoms.

Browse Medically Unexplained Symptoms studies →

Lead sponsor

Wayne State University is the lead sponsor of 230 studies on the registry; 35 are open to participants now.

Of its 17 completed or terminated interventional studies of FDA-regulated products, 4 (24%) have results posted.

Compared within Medically Unexplained Symptoms, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Anxiety Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria: university student, reporting at least moderate levels of anxiety (GAD-7) and somatic symptoms (PHQ-15) -

Exclusion Criteria: psychosis, lack of fluency with spoken and written English language

-

06

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
53 participants (actual)

Study arms

  • Experimental
    Emotional Awareness & Expression Therapy

    Participants will attend three individual sessions focused on becoming aware of and expressing avoided or conflicted emotions.

    Behavioral: Emotional Awareness & Expression Therapy

  • Experimental
    Mindfulness Meditation Training

    Participants will attend three individual sessions focused on increasing equanimity and compassion and reducing self-judgement.

    Behavioral: Mindfulness Meditation Training

  • No intervention
    Wait-List Control

    Participants will receive the intervention of their choice following assessment at four and eight weeks after randomization.

Interventions

  • BehavioralEmotional Awareness & Expression Therapy

    emotion-focused

  • BehavioralMindfulness Meditation Training

    meditation training and practice

07

What researchers measure

Primary outcomes

  1. Generalized Anxiety Scale-7

    symptoms of anxiety

    Time frame: change from baseline to four and eight weeks after baseline

  2. Patient Health Questionnaire-15

    The 15-item measure asks patients how much they have been bothered by various somatic symptoms such as headaches, back pain, and digestive distress during the previous 2 weeks, with answers ranging from 0 (not at all) to 2 (a lot). Items are summed to generate a total score with higher scores indicating greater distress regarding somatic symptoms.

    Time frame: change from baseline to four and eight weeks after baseline

Secondary outcomes

  1. Brief Symptom Inventory

    psychological symptoms

    Time frame: change from baseline to four and eight weeks after baseline

  2. Patient Global Impression of Change

    change in health status since the start of the study

    Time frame: four and eight weeks after baseline

  3. Perceived Stress Scale

    The 14-item measure asks patients how often they had experienced thoughts and feelings such as lack of control and difficulty coping during the previous 2 weeks, with answers ranging from 0 (never) to 4 (very often). Items are summed to generate a total score with higher scores indicating higher levels of perceived stress.

    Time frame: change from baseline to four and eight weeks after baseline

  4. Satisfaction With Life Scale

    The 5-item measure asks patients the degree to which they agree with statements such as "In most ways my life is close to my ideal", with answers ranging from 1 (strongly disagree) to 7 (strongly agree). Items are summed to create a total score with higher scores indicating a greater degree of satisfaction with life.

    Time frame: change from baseline to four and eight weeks after baseline

Other outcomes

  1. Emotional Approach Coping Scale

    emotional approach coping

    Time frame: change from baseline to four and eight weeks after baseline

  2. Emotional Expressivity Scale

    Measures the extent to which patients outwardly display emotion. The 17-item measure asks patients the degree to which items such as "I display my emotions to other people" describe them on a scale from 1 (never) to 6 (always). Scores are summed to generate a total score with higher scores indicating greater emotional expressiveness.

    Time frame: change from baseline to four and eight weeks after baseline

  3. Cognitive and Affective Mindfulness Scale-Revised

    The 12-item measure asks patients to rate the degree to which statements indicating four components of mindfulness (attention, focus on the present, awareness, and acceptance) apply to them, on a scale ranging from 1 (rarely/not at all) to 4 (almost always). Items are summed to generate a total score with higher scores indicating greater mindfulness.

    Time frame: change from baseline to four and eight weeks after baseline

  4. Acceptance and Action Questionnaire

    ). The 9-item measure assesses avoidance of private experiences such as emotions, thoughts, and memories as well as the ability to take action under adverse circumstances. It asks patients to indicate how true each statement is of themselves on a scale ranging from 1 (never true) to 7 (always true). Items are summed and higher scores indicate greater levels of psychological inflexibility.

    Time frame: change from baseline to four and eight weeks after baseline

08

Study locations

1 site
  • Wayne State University
    Detroit, Michigan 48202, United States
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2019 to primary completion in Apr 2020, 9 months.

Of 33 non-industry interventional studies with no phase under Medically Unexplained Symptoms, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's 9 months is below that.

Counting every sponsor, half of 33 studies reached it within 29 months; a quarter within 10 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 12, 2019
First posted
Jun 14, 2019
StartActual
Jul 5, 2019
Primary completionActual
Apr 28, 2020
CompletionActual
Apr 28, 2020
Last update
Jul 16, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 16, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03986125
Responsible party
Mark A. Lumley (Distinguished Professor, Wayne State University) — Principal investigator
First posted
Jun 14, 2019
Start date
Jul 5, 2019
Primary completion
Apr 28, 2020
Completion
Apr 28, 2020
Last update
Jul 16, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion